Literature DB >> 2710863

Attenuation of response to antidepressants in animals induced by reduction in food intake.

P Soubrié1, P Martin, J Massol, G Gaudel.   

Abstract

A salient feature of depression is eating disorders (reduced appetite and caloric intake) and/or weight loss. In the present study, reduction in food intake in rats, resulting in moderate weight loss, markedly attenuated the ability of various antidepressant drugs to reverse depressive-like behaviors: escape deficits provoked by previous exposure to uncontrollable stress. Further data support the notion that hypofunctioning of central noradrenergic processes, perhaps linked to reduced thyroid hormone levels, might contribute to such an altered response to antidepressants. These findings suggest that current nutritional status, even with marginal weight loss, could be an intervening factor in the delayed therapeutic response to antidepressants and/or in drug-resistant depression.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2710863     DOI: 10.1016/0165-1781(89)90130-3

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  4 in total

1.  Ingestion and emotional health.

Authors:  N K Dess
Journal:  Hum Nat       Date:  1991-09

2.  Parallel changes in dopamine D2 receptor binding in limbic forebrain associated with chronic mild stress-induced anhedonia and its reversal by imipramine.

Authors:  M Papp; V Klimek; P Willner
Journal:  Psychopharmacology (Berl)       Date:  1994-08       Impact factor: 4.530

3.  Food restriction and streptozotocin treatment decrease 5-HT1A and 5-HT2A receptor-mediated behavioral effects in rats.

Authors:  Jun-Xu Li; Charles P France
Journal:  Behav Pharmacol       Date:  2008-07       Impact factor: 2.293

4.  Reduced effectiveness of escitalopram in the forced swimming test is associated with increased serotonin clearance rate in food-restricted rats.

Authors:  Charles P France; Jun-Xu Li; William A Owens; Wouter Koek; Glenn M Toney; Lynette C Daws
Journal:  Int J Neuropsychopharmacol       Date:  2009-05-07       Impact factor: 5.176

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.